Hormonal conditions such as hypothyroidism or PCOS may also influence the rate of weight loss and should be assessed by a clinician
exenatide The enhanced satiety is a dose-dependent effect Combining soluble fiber with GLP-1 agonists increase weight loss results Gut Hormone & Bariatric Surgery GLP-1based Type-2 Diabetes (T2D) therapies are now commonly used in combination with other drugs with the added weight-loss effect broadening its therapeutic application in human obesity
Adverse reactions reported in pediatric patients 10 years of age and older treated with MOUNJARO were similar to those reported in adults with the exception of a higher incidence of vomiting, abdominal pain, and hypoglycemia [see Adverse Reactions (6.1)]
Apperloo EM, Neuen BL, Fletcher RA, et al
Lilly Zepbound How to Use page (Lilly) acceptable tirzepatide injection sites, rotation guidance, pen/vial demonstration, and disposal tips